Bao, Hua
Wang, Zheng
Ma, Xiaoji
Guo, Wei
Zhang, Xiangyu
Tang, Wanxiangfu
Chen, Xin
Wang, Xinyu
Chen, Yikuan
Mo, Shaobo
Liang, Naixin
Ma, Qianli
Wu, Shuyu
Xu, Xiuxiu
Chang, Shuang
Wei, Yulin
Zhang, Xian
Bao, Hairong
Liu, Rui
Yang, Shanshan
Jiang, Ya
Wu, Xue
Li, Yaqi
Zhang, Long
Tan, Fengwei
Xue, Qi
Liu, Fangqi
Cai, Sanjun
Gao, Shugeng
Peng, Junjie
Zhou, Jian
Shao, Yang
Article History
Received: 1 February 2022
Accepted: 15 May 2022
First Online: 11 June 2022
Declarations
:
: The study was approved by the Ethics Committees of the Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, China-Japan Friendship Hospital, Zhongshan Hospital Fudan University, and Fudan University Shanghai Cancer Center, Shanghai Cancer Center Institutional Review Board, and in accordance with international standards of good clinical practice. Written informed consent was obtained by all participants.
: We have received consent for publication from individuals who have participated in this study.
: Hua B, WT, XC, SW, XX, Shuang C, YW, Xian Z, Hairong B, RL, SSY, YJ, Xue W, and YS are employees of Nanjing Geneseeq Technology Inc., China. All other authors have declared no conflicts of interest.